Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNorcros Regulatory News (NXR)

Share Price Information for Norcros (NXR)

Share Price is delayed by 15 minutes
Get Live Data
277.00    -12.00 (-4.15%)
Bid:
275.00
Ask:
279.00
Spread: 4.00 (1.455%)
Market Cap: £248.99m
NXR Live PriceLast checked at - London Stock Exchange

Intraday Norcros Share Chart

Trading Update

12 Oct 2023 07:00

RNS Number : 8612P
Norcros PLC
12 October 2023
 

 

12 October 2023 

 

Trading update

Norcros plc, a market leading group providing design led, high quality bathroom and kitchen products, today releases its scheduled trading update ahead of announcing its Interim Results for the 26 weeks to 1 October 2023 on 16 November 2023.

 

Robust trading performance in line with expectations

The Group delivered a robust H1 performance despite the challenging demand environment, reflecting market share gains driven by successful new product launches, the strength of our customer proposition and the breadth of our distribution channels.

 

 

H1 revenue increase/(decrease)

 

Reported

CC1

CC1 LFL2

UK

1%

1%

(1%)

South Africa

(25%)

(11%)

(11%)

Group

(8%)

(3%)

(4%)

 

In our UK business, reported revenue for the first half was 1% higher than the previous year and on a LFL2 basis, just 1% lower with Triton and Merlyn performing particularly strongly. We continue to proactively manage our capital allocation and, in this regard, will be reducing manufacturing capacity at Johnson Tiles (UK) by approximately 50% in response to lower UK tile demand. Costs associated with this of circa £1.4m will be reported separately as an exceptional item.

 

In South Africa, notwithstanding national energy supply constraints impacting home market demand, our market leading business, brands, and experienced management team, continued to take market share, albeit revenue for the first half was 11% lower than the record prior year on a CC1 basis.

 

Group revenue for the 26 week period is approximately £202m (2022: £219.9m), 4% lower on a constant currency LFL2 basis and 8% lower on a reported basis than the record prior year comparator.

 

Our performance in the first half of this financial year continues to reflect the strength of our in-house product development capabilities, leading brands and excellent customer service proposition. We expect to report an underlying operating profit in the first half of the year of no less than £21m (2022: £22.0m).

 

Financial position

The balance sheet remains strong with net debt of approximately £48m on a pre-IFRS16 basis (net debt of £58.9m as at 30 September 2022 and £49.9m as at 31 March 2023). This represents leverage of approximately 1.0x net debt to EBITDA. The Group has committed banking facilities of £130m maturing October 2026.

 

Senior management appointment

We are pleased to announce the appointment from 2 January 2024 of Helene Roberts to the executive committee of the Norcros Group as Managing Director for the UK and Ireland. Helene succeeds Thomas Willcocks following his appointment as Chief Executive Officer in April 2023. Helene joins from Robinson plc, the European plastic and packaging manufacturer, where she was CEO for four years. Helene brings extensive leadership experience and a strong track record in sustainable product development and sourcing.

 

Outlook

The Board remains confident that our experienced management teams and consistent execution of strategy will continue to deliver market share gains for the year ending 31 March 2024 and expect full year operating profit to be in line with market expectations 3.

 

1. CC refers to constant currency basis 

2. LFL (like for like) adjusted for Grant Westfield (acquired 31 May 2022) and Norcros Adhesives

3. Norcros compiled market consensus for the year to 31 March 2024 is for an underlying operating profit of £43.4 million

 

 

 

Enquiries

Norcros plc

Tel: 01625 547700

Thomas Willcocks, Chief Executive Officer

James Eyre, Chief Financial Officer

Hudson Sandler

Tel: 0207 796 4133

Nick Lyon

Sophie Miles

Notes to Editors

Norcros is a design and service led bathroom and kitchen business with market leading brands operating primarily in the UK and South Africa.

 

In the UK, Norcros operates under seven brands, Triton, Merlyn, Multipanel (Grant Westfield), Vado, Croydex, Abode, and Johnson Tiles.

 

In South Africa, Norcros operates under four brands, Tile Africa, House of Plumbing, TAL, and Johnson Tiles.

 

Norcros is headquartered in Wilmslow, Cheshire and employs around 2,400 people. The Company is listed on the London Stock Exchange. For further information please visit the Company website: http://www.norcros.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTXFLLFXBLLFBE
Date   Source Headline
21st May 20267:00 amRNS-RInvestor Presentation Webinar on 18 June 2026
12th May 20267:00 amRNSStrategic update: South African operations
30th Apr 202611:42 amRNSTotal Voting Rights
16th Apr 20267:00 amRNSYear-end Trading and Board update
2nd Apr 20267:00 amRNSTotal Voting Rights
1st Apr 20267:00 amRNSBlock Listing Six Monthly Return
3rd Mar 20269:29 amRNSDirectors Share Dealing - correction
3rd Mar 20267:00 amRNSDirectors Share Dealing
2nd Feb 20267:00 amRNSAppointment of Joint Corporate Broker
14th Jan 202612:12 pmRNSDirectors Share Dealing
19th Dec 20253:52 pmRNSEmployee SAYE awards and director share dealing
19th Dec 20253:52 pmRNSEmployee SAYE awards and director share dealing
28th Nov 20254:03 pmRNSHolding(s) in Company
20th Nov 20256:22 pmRNSDirectors Share Dealing
20th Nov 20257:00 amRNSInterim Results
12th Nov 20257:00 amRNS-RInvestor Presentation Webinar on 1 December 2025
21st Oct 20255:04 pmRNSHolding(s) in Company
16th Oct 20257:00 amRNSTrading update
13th Oct 20257:24 amRNSCompletion of Acquisition of Fibo Holding AS
30th Sep 202511:46 amRNSBlock Listing Six Monthly Return
23rd Jul 202512:03 pmRNSDirector Dealings - APSP and DBP Share Options
23rd Jul 202511:59 amRNSResults of AGM
23rd Jul 20257:11 amRNSAGM Trading Statement
21st Jul 20254:11 pmRNSDirector Dealings - DBP Share Option exercises
16th Jul 20255:01 pmRNSTotal Voting Rights
15th Jul 20257:00 amRNSAcquisition of Fibo Holding AS
23rd Jun 20257:00 amRNSJTSA Outcome of Strategic Review
20th Jun 20254:10 pmRNSAnnual Financial Report and Notice of 2025 AGM
12th Jun 20257:00 amRNSResults for the year ended 31 March 2025
3rd Jun 20257:00 amRNS-RInvestor Webinar
10th Apr 20257:00 amRNSTrading update for the year ended 31 March 2025
31st Mar 20257:00 amRNSBlock Listing 6 Monthly Return
31st Mar 20257:00 amRNSTotal Voting Rights
13th Mar 20257:00 amRNSPension Scheme Valuation Update
5th Feb 20253:45 pmRNSDirectors Share Dealing
31st Dec 20247:00 amRNSVoting Rights and Share Capital Update
10th Dec 202411:49 amRNSHolding(s) in Company
6th Dec 202411:52 amRNSHolding(s) in Company
3rd Dec 20244:39 pmRNSTotal Voting Rights
21st Nov 20245:01 pmRNSHolding(s) in Company
21st Nov 202411:57 amRNSInterim Results - Replacement
21st Nov 20247:00 amRNSResults for the six months ended 30 September 2024
1st Nov 20247:00 amRNSTotal Voting Rights
10th Oct 20247:00 amRNSTrading update
1st Oct 20247:00 amRNSTotal Voting Rights
30th Sep 202410:08 amRNSBlock listing Six Monthly Return
30th Aug 20247:00 amRNSTotal Voting Rights
24th Jul 20241:50 pmRNSResults of AGM
24th Jul 20241:24 pmRNSDirector Dealings - APSP Share Option Awards
24th Jul 20247:00 amRNSAGM Trading Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.